Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Nasdaq Biotechnology Ishares ETF (NQ: IBB)
111.22 USD  -1.78 (-1.58%)
Official Closing Price  /  Updated: 7:41 PM EDT, Oct 19, 2018  /  Add to My Watchlist      
View: Quote News
Fund Overview
Nasdaq Biotechnology Ishares ETF
Sector
Exchange Traded NQ
Net Assets 9.67B
Inception Date
Related Funds
Quote
Price 111.22
Volume 1,550,600
Last Trade Oct 19, 7:41pm
Change (%)
-1.78 (-1.58%)
Prev. Close 113.00
YTD %
+1.72%
Dividend Yield 0.29%
Performance
YTD
+1.88 (1.72%)
1 Month
-6.44 (-5.47%)
3 Month
-7.04 (-5.95%)
6 Month
+6.26 (5.96%)
1 Year
-223.89 (-66.81%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
Top News
More News
The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
Biotech Bull Market Under Pressure: Now Flat to Down in 2018
Here are some positive and negative indicators to consider on the future direction of biotechnology stocks. Read More
from Blogs - TalkMarkets
iShares Nasdaq Biotechnology (IBB) Shares Cross Above 200 DMA
In trading on Tuesday, shares of the iShares Nasdaq Biotechnology ETF (IBB) crossed above their 200 day moving average of $112.01, changing hands as high as $112.43 per share. iShares Nasdaq... Read More
from ETF Channel
The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
Drug Companies To Disclose Pricing Information In Ads
When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized. The price of the ... Read More
from Benzinga
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
Here are a few catalysts that can dictate the directional moves of biotech stocks in the upcoming week: Conferences European ... Read More
from Benzinga
In Any Language, Market Puts Up a Cautionary Sign
If ripened fruit has not been picked from a tree, it will eventually fall. Considering how overripe the market and economy have been, not surprising many traders got a nasty bump on their heads. Read More
from Blogs - TalkMarkets
IBB, GILD, BIIB, CELG: Large Inflows Detected at ETF
Symbols mentioned in this story: IBB, GILD, BIIB, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
from ETF Channel
The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program
Here's a roundup of top developments in the biotech space over the last 24 hours. Amid the market mayhem, no biotech or medical ... Read More
from Benzinga
Breakdown in Daily and Weekly Charts; Monthly?
The number of stocks under the 10-Day moving average in the S&P 500 hit an extreme. So did the new highs/new lows ratio. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... Read More
from Benzinga
Buy on the Dip Prospects: October 10 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.